Personal information

Emails & domains

Verified email addresses

Verified email domains

Other IDs

SciProfiles: 2088987
Loop profile: 1960283

Countries

Hungary

Activities

Collapse all

Education and qualifications (1)

University of Debrecen: Debrecen, HU

2016 | MSc Molecular Biology
Education
Source: Self-asserted source
Ilona Tornyi

Works (12)

Comparative proteome and serum analysis identified FSCN1 as a marker of abiraterone resistance in castration-resistant prostate cancer

Prostate Cancer and Prostatic Diseases
2024-09 | Journal article
DOI: 10.1038/s41391-023-00713-y
Contributors: Anita Csizmarik; Nikolett Nagy; Dávid Keresztes; Melinda Váradi; Thilo Bracht; Barbara Sitek; Kathrin Witzke; Martin Puhr; Ilona Tornyi; József Lázár et al.
Source: check_circle
Crossref

The role of immunotherapy in early-stage and metastatic NSCLC

Pathology and Oncology Research
2024-07-04 | Journal article
DOI: 10.3389/pore.2024.1611713
Part of ISSN: 1532-2807
Contributors: Attila Lieber; Attila Makai; Zsuzsanna Orosz; Tamás Kardos; Susil Joe Isaac; Ilona Tornyi; Nóra Bittner
Source: Self-asserted source
Ilona Tornyi

Role of Complement Components in Asthma: A Systematic Review

Journal of Clinical Medicine
2024-05-22 | Journal article
DOI: 10.3390/jcm13113044
Contributors: Ilona Tornyi; Ildikó Horváth
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Co-Morbidity Clusters in Post-COVID-19 Syndrome

Journal of Clinical Medicine
2024-03-02 | Journal article
DOI: 10.3390/jcm13051457
Contributors: Anna Teréz Sárközi; Ilona Tornyi; Erik Békési; Ildikó Horváth
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with “bone-only” metastatic breast cancer

Pathology and Oncology Research
2023-10-11 | Journal article
DOI: 10.3389/pore.2023.1611369
Part of ISSN: 1532-2807
Contributors: Ilona Tornyi; Peter Árkosy; Ildikó Horváth; Andrea Furka
Source: Self-asserted source
Ilona Tornyi

Epitomics: Analysis of Plasma C9 Epitope Heterogeneity in the Plasma of Lung Cancer Patients and Control Subjects

International Journal of Molecular Sciences
2023-09-21 | Journal article
DOI: 10.3390/ijms241814359
Contributors: Ilona Tornyi; Jozsef Lazar; Aladar Pettko-Szandtner; Eva Hunyadi-Gulyas; Laszlo Takacs
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Large-Scale Plasma Proteome Epitome Profiling is an Efficient Tool for the Discovery of Cancer Biomarkers

Molecular & Cellular Proteomics
2023-07 | Journal article
DOI: 10.1016/j.mcpro.2023.100580
Contributors: Jozsef Lazar; Peter Antal-Szalmas; Istvan Kurucz; Annamaria Ferenczi; Mihaly Jozsi; Ilona Tornyi; Monika Muller; Janos Tibor Fekete; John Lamont; Peter FitzGerald et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Full Body Surface Coverage with Water-Equivalent Bolus as Novel Technique for Total Body Irradiation before Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoid Leukemia

Children
2022-11-12 | Journal article
DOI: 10.3390/children9111740
Contributors: Andrea Furka; Zsofia Nagy; Imre Szabó; Gábor Fekete; Ágnes Kelemen; Gábor Bolobás; Gábriel Sebők; Tünde Molnár; János Árvai; Ilona Tornyi et al.
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified <scp>ALCAM</scp> as marker of resistance in castration‐resistant prostate cancer

International Journal of Cancer
2022-06-11 | Journal article
DOI: 10.1002/ijc.34159
Part of ISSN: 0020-7136
Part of ISSN: 1097-0215
Source: Self-asserted source
Ilona Tornyi
grade
Preferred source (of 2)‎

Detection of leucine-rich alpha-2-glycoprotein 1-containing immunocomplexes in the plasma of lung cancer patients with epitope-specific mAbs

Cancer Biomarkers
2022-04-18 | Journal article
DOI: 10.3233/CBM-210164
Source: Self-asserted source
Ilona Tornyi
grade
Preferred source (of 2)‎

Treatment Algorithm for Cancerous Wounds: A Systematic Review

Cancers
2022-02-25 | Journal article
DOI: 10.3390/cancers14051203
Contributors: Andrea Furka; Csaba Simkó; László Kostyál; Imre Szabó; Anikó Valikovics; Gábor Fekete; Ilona Tornyi; Endre Oross; János Révész
Source: check_circle
Crossref
grade
Preferred source (of 3)‎

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer

Journal of Cellular and Molecular Medicine
2021-12-30 | Journal article
DOI: 10.1111/jcmm.17141
Part of ISSN: 1582-1838
Part of ISSN: 1582-4934
Source: Self-asserted source
Ilona Tornyi
grade
Preferred source (of 2)‎

Peer review (2 reviews for 2 publications/grants)

Review activity for Expert reviews in molecular medicine. (1)
Review activity for Molecular and cellular probes (1)
How many people are using ORCID?